Fingerprint
Dive into the research topics of 'Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Philip A. Philip, Michelle R. Mahoney, Kyle D. Holen, Donald W. Northfelt, Henry C. Pitot, Joel Picus, Patrick J. Flynn, Charles Erlichman
Research output: Contribution to journal › Article › peer-review